'Insulin autoantibody affinity measurement using a single concentration of unlabelled insulin competitor discriminates risk in relatives of patients with type 1 diabetes

Clinical and Experimental Immunology

Volumn 167, Issue 1, 2012, Pages 67-72

  Curnock, R M ^a   Reed, C R ^a   Rokni, S ^a   Broadhurst, J W ^a   Bingley, P J ^a   Williams, A J K ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Affinity; Insulin autoantibodies; Prediction; Progression

Indexed keywords

AUTOANTIBODY; INSULIN; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ANTIBODY AFFINITY; ARTICLE; BINDING ASSAY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE COURSE; DISEASE MARKER; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RELATIVE; RISK; SCHOOL CHILD;

ADOLESCENT; ADULT; ANTIBODY AFFINITY; AUTOANTIBODIES; AUTOANTIGENS; BINDING, COMPETITIVE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FAMILY HEALTH; FEMALE; FOLLOW-UP STUDIES; GLUTAMATE DECARBOXYLASE; HUMANS; INSULIN; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; RISK; YOUNG ADULT;

EID: 82655171673     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04495.x     Document Type: Article

References (17)

1. Srikanta S, Ricker AT, McCulloch DK, Soeldner JS, Eisenbarth GS, Palmer JP. Autoimmunity to insulin, beta cell dysfunction, and development of insulin-dependent diabetes mellitus. Diabetes 1986; 35:139-42.
2. Ziegler AG, Hummel M, Schenker M, Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 1999; 48:460-8.
3. Greenbaum CJ, Palmer JP, Kuglin B, Kolb H. Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurement. J Clin Endocrinol Metab 1992; 74:1040-4.
4. Palmer JP, Asplin CM, Clemons P etal. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222:1337-9.
5. Williams AJ, Bingley PJ, Bonifacio E, Palmer JP, Gale EA. A novel micro-assay for insulin autoantibodies. J Autoimmun 1997; 10:473-8.
6. Naserke HE, Dozio N, Ziegler AG, Bonifacio E. Comparison of a novel micro-assay for insulin autoantibodies with the conventional radiobinding assay. Diabetologia 1998; 41:681-3.
7. Williams AJ, Norcross AJ, Chandler KA, Bingley PJ. Non-specific binding to protein A Sepharose and protein G Sepharose in insulin autoantibody assays may be reduced by pre-treatment with glycine or ethanolamine. J Immunol Methods 2006; 314:170-3.
8. Yu L, Robles DT, Abiru N etal. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci USA 2000; 97:1701-6.
9. Williams AJ, Curnock R, Reed CR, Easton P, Rokni S, Bingley PJ. Anti-BSA antibodies are a major cause of non-specific binding in insulin autoantibody radiobinding assays. J Immunol Methods 2010; 362:199-203.
10. Bingley PJ, Williams AJ, Gale EA. Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials. Diabetes Care 1999; 22:1796-801.
11. Achenbach P, Koczwara K, Knopff A, Naserke H, Ziegler AG, Bonifacio E. Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest 2004; 114:589-97.
12. Schlosser M, Koczwara K, Kenk H etal. In insulin-autoantibody-positive children from the general population, antibody affinity identifies those at high and low risk. Diabetologia 2005; 48:1830-2.
13. Achenbach P, Schlosser M, Williams AJ etal. Combined testing of antibody titer and affinity improves insulin autoantibody measurement: diabetes Antibody Standardization Program. Clin Immunol 2007; 122:85-90.
14. Achenbach P, Guo LH, Gick C etal. A simplified method to assess affinity of insulin autoantibodies. Clin Immunol 2010; 137:415-21.
15. Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 1997; 46:1701-10.
16. Siljander H, Harkonen T, Hermann R etal. Role of insulin autoantibody affinity as a predictive marker for type 1 diabetes in young children with HLA-conferred disease susceptibility. Diabetes Metab Res Rev 2009; 25:615-22.
17. Mayr A, Schlosser M, Grober N etal. GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes. Diabetes 2007; 56:1527-33.